Graypoint LLC’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Buy |
13,271
+1,115
| +9% | +$124K | 0.08% | 165 |
|
|
2025
Q1 | $1.36M | Buy |
12,156
+965
| +9% | +$108K | 0.08% | 160 |
|
|
2024
Q4 | $1.03M | Buy |
11,191
+1,249
| +13% | +$115K | 0.06% | 196 |
|
|
2024
Q3 | $834K | Buy |
9,942
+1,621
| +19% | +$136K | 0.05% | 216 |
|
|
2024
Q2 | $571K | Sell |
8,321
-2,282
| -22% | -$157K | 0.04% | 255 |
|
|
2024
Q1 | $777K | Sell |
10,603
-215
| -2% | -$15.7K | 0.06% | 210 |
|
|
2023
Q4 | $876K | Buy |
10,818
+745
| +7% | +$60.4K | 0.07% | 184 |
|
|
2023
Q3 | $755K | Buy |
10,073
+2,722
| +37% | +$204K | 0.07% | 180 |
|
|
2023
Q2 | $567K | Buy |
7,351
+670
| +10% | +$51.6K | 0.06% | 199 |
|
|
2023
Q1 | $554K | Buy |
6,681
+1,391
| +26% | +$115K | 0.06% | 189 |
|
|
2022
Q4 | $454K | Sell |
5,290
-1,077
| -17% | -$92.5K | 0.05% | 204 |
|
|
2022
Q3 | $393K | Buy |
+6,367
| New | +$393K | 0.05% | 212 |
|